Altanova Pharma Group AG is a Swiss-led specialty pharma platform focused on compliant sourcing, pharmaceutical-quality standards and medical-channel access across Switzerland and selected European markets.
Altanova operates the regulated access layer no current operator has built under one roof: a Swissmedic-anchored quality system, multi-jurisdictional supply discipline, specialty-pharma medical-channel access, and an AI-enabled compliance and analytics stack.
Manufacturing and batch release under EU-GMP Annex 16. European Pharmacopoeia testing across cannabinoid content, residual solvents, heavy metals, pesticides, mycotoxins and microbiological contamination.
Quality framework →Responsible Person under Art. 5 AMBV and Qualified Person under EU-GMP Annex 16. Non-delegable accountability for batch certification and quality compliance.
Regulatory framework →Qualified EU-GMP partners across selected European markets, supported by per-shipment authorisation frameworks. Asset-light by construction; resilience at every link of the chain.
Supply integrity →Specialty-pharmacy partnerships, hospital-formulary engagement and physician medical-affairs infrastructure built to specialty-pharma standards. Non-promotional in character.
Medical & Scientific Education →